Press release
Next Generation Sequencing Market to Reach USD 32.6 Billion by 2030
Next Generation Sequencing
NGS delivers high-throughput, cost-efficient, and extremely precise genetic data-transforming healthcare, biomedical research, public health surveillance, and clinical decision-making.
Download Full PDF Sample Copy of Market Report @ https://exactitudeconsultancy.com/request-sample/73538
Key Takeaways
• Market Size 2023: USD 11.7 billion
• Market Size 2030: USD 32.6 billion
• CAGR (2024-2030): 15.8%
• Largest Application: Oncology & cancer genomics
• Fastest-Growing Segment: Clinical diagnostics & precision medicine
Market Story
NGS technologies have become the backbone of modern genomics. They enable:
• Whole genome sequencing (WGS)
• Whole exome sequencing (WES)
• RNA-Seq & transcriptomics
• Single-cell sequencing
• Targeted gene panels for oncology
• Metagenomics & microbiome profiling
• Pathogen surveillance (viral/bacterial)
• Inherited genetic disease testing
Drivers of explosive market growth include:
• Expansion of precision oncology and targeted therapy programs
• Rising burden of cancer and rare genetic diseases
• Increasing public health sequencing post-COVID-19
• Adoption of liquid biopsy & circulating tumor DNA (ctDNA) testing
• Government-funded population genomics programs
• Advances in data analytics, AI, and cloud-based bioinformatics
NGS is moving from research labs to mainstream hospitals and diagnostic centers at record speed.
Market Segments
By Technology
• Sequencing by Synthesis (SBS) - Largest Segment
• Ion Semiconductor Sequencing
• Nanopore Sequencing - Fastest Growing
• Single-Molecule Real-Time (SMRT) Sequencing
• Pyrosequencing
SBS dominates due to extensive Illumina platform adoption.
By Product & Service
• NGS Instruments
• NGS Consumables (Largest Revenue Contributor)
- Kits, reagents, flow cells
• Bioinformatics Software & Services (Fastest Growing)
• Library Preparation Kits
• Sample Extraction Kits
• Data Analysis & Cloud-Based Interpretation Services
Consumables and bioinformatics represent major recurring revenue sources.
By Application
• Oncology (Largest Application)
• Clinical Diagnostics
- Infectious disease genomics
- Genetic disorders
- Pharmacogenomics
• Drug Discovery & Development
• Agrigenomics
• Forensic Genomics
• Reproductive & Prenatal Genomics
• Metagenomics & Microbiome Research
• Single-Cell & Spatial Genomics (Emerging High-Growth)
Oncology continues to dominate due to the need for actionable molecular insights.
By Sequencing Method
• Whole Genome Sequencing (WGS)
• Whole Exome Sequencing (WES)
• RNA-Seq
• Targeted Sequencing (Largest Segment)
• Single-Cell Sequencing
• Spatial Transcriptomics
Targeted sequencing dominates due to clinical relevance and cost-efficiency.
By End User
• Hospitals & Clinical Diagnostic Labs (Fastest Growing End User)
• Biopharma & Biotechnology Companies
• Academic & Research Institutions
• CROs
• Government & Public Health Agencies
The shift of NGS into clinical diagnostics is accelerating dramatically worldwide.
Explore Full Report here: https://exactitudeconsultancy.com/reports/73538/next-generation-sequencing-market
Recent Industry Developments
• 2024 - Illumina released new high-throughput sequencers with enhanced speed and reduced sequencing costs.
• 2023 - Thermo Fisher Scientific expanded its clinical oncology panel portfolio for NGS-based precision medicine.
• 2023 - PacBio launched new long-read sequencing systems optimized for HiFi accuracy.
• 2023 - Oxford Nanopore Technologies advanced nanopore sequencing for clinical-grade applications.
• 2023 - Qiagen launched multiple NGS automation and sample prep solutions for hospitals and labs.
Expert Quote
"NGS is becoming the foundation of precision medicine. As sequencing integrates deeper into oncology, newborn screening, and infectious disease surveillance, global adoption will accelerate at an unprecedented pace."
- Irfan Tamboli, Business Development Executive, Exactitude Consultancy
Key Market Drivers
1. Surge in Precision Oncology
NGS enables targeted therapy selection, mutation detection, and real-time treatment monitoring.
2. Growth of Genetic Disease Testing
WGS and WES are used to diagnose rare hereditary disorders.
3. Public Health Sequencing Expansion
NGS supports real-time pathogen tracking, variant detection, and outbreak surveillance.
4. Cost Reduction & Technological Advancements
Sequencing costs continue to fall, enabling broader adoption.
5. AI-Driven Analytics & Cloud Bioinformatics
Advanced platforms accelerate data interpretation and clinical reporting.
Forecast Outlook (2024-2030)
Future developments include:
• Expansion of clinical-grade long-read sequencing
• Integration of NGS with radiogenomics & proteogenomics
• Growth of decentralized hospital-based sequencing centers
• Enhanced liquid biopsy sequencing for cancer monitoring
• Whole-genome sequencing mainstreaming in newborn screening
By 2030, NGS will be a routine component of global healthcare, research, and disease surveillance ecosystems.
Regional Insights
North America
Largest market thanks to strong clinical adoption, established genomics companies, and high R&D funding.
Europe
Strong genomics infrastructure with national sequencing initiatives (UK, Germany, France).
Asia-Pacific (Fastest Growing Region)
Rapid expansion of cancer sequencing, population genomics, and biotech research in China, India, Japan, and South Korea.
Latin America & Middle East
Increasing adoption across public health labs and clinical genomics programs.
Conclusion
The Next Generation Sequencing Market is entering a transformative growth phase driven by precision medicine, oncology, and infectious disease genomics. With rapid advances in sequencing technology, bioinformatics, and clinical applications, NGS is positioned to redefine global healthcare and research through 2030.
This report is also available in the following languages : Japanese (次世代シーケンシング市場), Korean (차세대 시퀀싱 시장), Chinese (下一代测序市场), French (Marché du séquençage de nouvelle génération), German (Markt für Next-Generation-Sequenzierung), and Italian (Mercato del sequenziamento di nuova generazione), etc.
Request for a sample of this research report at (Use Corporate Mail ID for Quick Response) @ https://exactitudeconsultancy.com/request-sample/73538
Related Reports
Non-Terrestrial Network Solution Market
https://exactitudeconsultancy.com/reports/74931/non-terrestrial-network-solution-market
Next Generation Sequencing Services Market
https://exactitudeconsultancy.com/reports/72395/next-generation-sequencing-services-market
Next Generation Drug Conjugates Market
https://exactitudeconsultancy.com/reports/72418/next-generation-drug-conjugates-market
Single Cell Analysis Market
https://exactitudeconsultancy.com/reports/73200/single-cell-analysis-market
About Us
Exactitude Consultancy is a market research & consulting services firm which helps its client to address their most pressing strategic and business challenges. Our market research helps clients to address critical business challenges and also helps make optimized business decisions with our fact-based research insights, market intelligence, and accurate data.
https://bulletin.exactitudeconsultancy.com/
https://www.thehealthanalytics.com/
https://www.analytica.global/
https://www.marketintelligencedata.com/
https://www.marketinsightsreports.com/
https://exactitudeconsultancy.com/
Connect Us:
Irfan Tamboli
PHONE NUMBER +1 (704) 266-3234
EMAIL ADDRESS: sales@exactitudeconsultancy.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Next Generation Sequencing Market to Reach USD 32.6 Billion by 2030 here
News-ID: 4293172 • Views: …
More Releases from Exactitude Consultancy
Automated Cell Processing System Market to Reach USD 8.41 Billion by 2030
The Global Automated Cell Processing System Market is growing rapidly as cell therapies, gene therapies, stem cell treatments, and advanced regenerative medicine move toward large-scale clinical and commercial adoption. According to Exactitude Consultancy, the market is projected to rise from USD 2.9 billion in 2023 to USD 8.41 billion by 2030, expanding at a robust CAGR of 16.4%.
Automated cell processing systems streamline and standardize cell isolation, expansion, activation, washing, concentration,…
Single-Use Bioreactors Market to Reach USD 14.9 Billion by 2030
The Global Single-Use Bioreactors Market is expanding rapidly as biopharmaceutical manufacturers, CDMOs, and advanced therapy producers increasingly choose disposable bioreactors over traditional stainless-steel systems. According to Exactitude Consultancy, the market size is projected to rise from USD 5.4 billion in 2023 to USD 14.9 billion by 2030, achieving a strong CAGR of 15.4%.
Single-use bioreactors (SUBs) enable flexible, contamination-resistant, and cost-efficient production-making them essential for mAbs, vaccines, recombinant proteins, viral vectors,…
Continuous Manufacturing Systems Market to Reach USD 2.98 Billion by 2030
The Global Continuous Manufacturing Systems Market is expanding rapidly as industries shift from traditional batch processing to real-time, efficient, and automation-driven continuous production. According to Exactitude Consultancy, the market is projected to increase from USD 1.42 billion in 2023 to USD 2.98 billion by 2030, growing at a notable CAGR of 10.6%.
Continuous manufacturing systems are increasingly deployed in pharmaceuticals, chemicals, food processing, and advanced materials due to their benefits in…
Continuous Bioprocessing Market to Reach USD 18.6 Billion by 2030
The Global Continuous Bioprocessing Market is accelerating as biologics, biosimilars, vaccines, and emerging cell & gene therapies increasingly adopt continuous, real-time, and highly controlled manufacturing approaches. According to Exactitude Consultancy, the market is expected to grow from USD 6.2 billion in 2023 to USD 18.6 billion by 2030, registering an impressive CAGR of 16.9%.
Continuous bioprocessing enables uninterrupted production, improved efficiency, reduced footprint, lower costs, and superior product consistency compared to…
More Releases for Sequencing
Sequencing Reagents Market Report 2024 - Sequencing Reagents Market Trends And S …
"The Business Research Company recently released a comprehensive report on the Global Sequencing Reagents Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Sequencing the Future: Next Generation Sequencing Market Projections (2023-2033)
The global Next-generation Sequencing Market was over 8.5 billion in 2022 and it is anticipated to grow at a CAGR of over 18.2% during the forecast period.
Market Outlook:
The Next Generation Sequencing (NGS) market is set for an extraordinary trajectory of growth and innovation from 2023 to 2033. This decade is poised to witness a paradigm shift in genomics and molecular biology, with NGS technologies playing a central role in reshaping…
Sequencing Reagents Market - Elevating Accuracy, Inspiring Discovery: Revolution …
Newark, New Castle, USA - new report, titled Sequencing Reagents Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Sequencing Reagents market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Sequencing Reagents market. The report offers an overview of the market, which…
Microbiome Sequencing Services Market By Technology (Sequencing By Synthesis (SB …
Microbiome are the group of microorganisms that grow on saliva, skin layers, conjunctiva, oral mucosa and the gastrointestinal tract. Microbiome sequencing is the study and analysis of microbes groups located outside and inside of the human body to gain knowledge about human microbes.
Download Sample PDF at https://www.theinsightpartners.com/sample/TIPRE00004419/?utm_source=OpenPR&utm_medium=10379
Key Players Analysis:
Baseclear B.V.
Clinical-Microbiomics A/S
Molzym GmbH & Co. Kg
Zymo Research Corp.
Rancho Biosciences
Microbiome Therapeutics, LLC.
Microbiome Insights Inc.
Openbiome
Resphera Biosciences, LLC.
Ubiome, Inc.
The report covers key developments…
Next Generation Sequencing Market Growth of Technological Advancements in Sequen …
Research Report on Next Generation Sequencing Market providing Global Industry Scenario for 5 years (2019 to 2026) is now available under the Life Sciences Section of Search4Research.com
Get Research Sample PDF at https://www.search4research.com/request-sample/113582/
Global Next Generation Sequencing Market Trends, Competitive Analysis and Forecast Report 2018-2026 is an exhaustive study on the present market scenario of the global Next Generation Sequencing industry with a special focus on the United States, Europe,…
Metagenomic Sequencing Market Technology Outlook 2027 - 16s Rrna Sequencing, Sho …
Worldwide Metagenomic Sequencing Market Analysis to 2027 is a specialized and in-depth study of the Metagenomic Sequencing Industry with a focus on the global market trend. The report aims to provide an overview of global Metagenomic Sequencing Market with detailed market segmentation by product/application and geography. The global Metagenomic Sequencing Market is expected to witness high growth during the forecast period.
Metagenomics, is a field where genomic analysis of microbial DNA…
